Selected research
Industry Growth & Trends
Global Livestock Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
The global Livestock Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Livestock Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Livestock Vaccines include Boehringer Ingelheim, Ceva, Elanco, Harbin Pharmaceutical Group, Hester Biosciences, Hile, Japfa Comfeed Indonesia, JinYu Biotechnology and MEVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Livestock Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Livestock Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Livestock Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Livestock Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Livestock Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Livestock Vaccines Market by Company
Boehringer Ingelheim
Ceva
Elanco
Harbin Pharmaceutical Group
Hester Biosciences
Hile
Japfa Comfeed Indonesia
JinYu Biotechnology
MEVAC
Nisseiken
Phibro Animal Health Corporation
Pulike
QYH Biotech Co., Ltd
Vaxxinova®
Venky's
Zoetis
Merck
Livestock Vaccines Segment by Type
Foot and Mouth Disease Vaccine
Bird Flu Vaccine
Porcine Blue Ear Vaccine
Swine Fever Vaccine
Pig Ring Vaccine
Livestock Vaccines Segment by Application
Pig
Cattle and Sheep
Others
Livestock Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Livestock Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Foot and Mouth Disease Vaccine
- Bird Flu Vaccine
- Porcine Blue Ear Vaccine
- Swine Fever Vaccine
- Pig Ring Vaccine
Applications
- Pig
- Cattle and Sheep
- Others
Companies covered
- Boehringer Ingelheim
- Ceva
- Elanco
- Harbin Pharmaceutical Group
- Hester Biosciences
- Hile
- Japfa Comfeed Indonesia
- JinYu Biotechnology
- MEVAC
- Nisseiken
- Phibro Animal Health Corporation
- Pulike
- QYH Biotech Co., Ltd
- Vaxxinova®
- Venky's
- Zoetis
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Livestock Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Livestock Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.3 Livestock Vaccines Market by Type
- 1.3.1 Foot and Mouth Disease Vaccine
- 1.3.2 Bird Flu Vaccine
- 1.3.3 Porcine Blue Ear Vaccine
- 1.3.4 Swine Fever Vaccine
- 1.3.5 Pig Ring Vaccine
- 1.4 Global Livestock Vaccines Market Size by Type
- 1.4.1 Global Livestock Vaccines Market Size Overview by Type (2021-2032)
- 1.4.2 Global Livestock Vaccines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Livestock Vaccines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Livestock Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Livestock Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Livestock Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Livestock Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Livestock Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Livestock Vaccines Industry Trends
- 2.2 Livestock Vaccines Industry Drivers
- 2.3 Livestock Vaccines Industry Opportunities and Challenges
- 2.4 Livestock Vaccines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Livestock Vaccines Revenue (2021-2026)
- 3.2 Global Top Players by Livestock Vaccines Sales (2021-2026)
- 3.3 Global Top Players by Livestock Vaccines Price (2021-2026)
- 3.4 Global Livestock Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Livestock Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Livestock Vaccines Company, Product Type & Application
- 3.7 Global Livestock Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Livestock Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Livestock Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Livestock Vaccines Tier 1, Tier 2, and Tier 3
4 Livestock Vaccines Regional Status and Outlook
- 4.1 Global Livestock Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Livestock Vaccines Historic Market Size by Region
- 4.2.1 Global Livestock Vaccines Sales in Volume by Region (2021-2026)
- 4.2.2 Global Livestock Vaccines Sales in Value by Region (2021-2026)
- 4.2.3 Global Livestock Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Livestock Vaccines Forecasted Market Size by Region
- 4.3.1 Global Livestock Vaccines Sales in Volume by Region (2027-2032)
- 4.3.2 Global Livestock Vaccines Sales in Value by Region (2027-2032)
- 4.3.3 Global Livestock Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Livestock Vaccines by Application
- 5.1 Livestock Vaccines Market by Application
- 5.1.1 Pig
- 5.1.2 Cattle and Sheep
- 5.1.3 Others
- 5.2 Global Livestock Vaccines Market Size by Application
- 5.2.1 Global Livestock Vaccines Market Size Overview by Application (2021-2032)
- 5.2.2 Global Livestock Vaccines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Livestock Vaccines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Livestock Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Livestock Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Livestock Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Livestock Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Livestock Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 Ceva
- 6.2.1 Ceva Company Information
- 6.2.2 Ceva Business Overview
- 6.2.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Ceva Livestock Vaccines Product Portfolio
- 6.2.5 Ceva Recent Developments
- 6.3 Elanco
- 6.3.1 Elanco Company Information
- 6.3.2 Elanco Business Overview
- 6.3.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Elanco Livestock Vaccines Product Portfolio
- 6.3.5 Elanco Recent Developments
- 6.4 Harbin Pharmaceutical Group
- 6.4.1 Harbin Pharmaceutical Group Company Information
- 6.4.2 Harbin Pharmaceutical Group Business Overview
- 6.4.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
- 6.4.5 Harbin Pharmaceutical Group Recent Developments
- 6.5 Hester Biosciences
- 6.5.1 Hester Biosciences Company Information
- 6.5.2 Hester Biosciences Business Overview
- 6.5.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hester Biosciences Livestock Vaccines Product Portfolio
- 6.5.5 Hester Biosciences Recent Developments
- 6.6 Hile
- 6.6.1 Hile Company Information
- 6.6.2 Hile Business Overview
- 6.6.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hile Livestock Vaccines Product Portfolio
- 6.6.5 Hile Recent Developments
- 6.7 Japfa Comfeed Indonesia
- 6.7.1 Japfa Comfeed Indonesia Company Information
- 6.7.2 Japfa Comfeed Indonesia Business Overview
- 6.7.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
- 6.7.5 Japfa Comfeed Indonesia Recent Developments
- 6.8 JinYu Biotechnology
- 6.8.1 JinYu Biotechnology Company Information
- 6.8.2 JinYu Biotechnology Business Overview
- 6.8.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
- 6.8.5 JinYu Biotechnology Recent Developments
- 6.9 MEVAC
- 6.9.1 MEVAC Company Information
- 6.9.2 MEVAC Business Overview
- 6.9.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 MEVAC Livestock Vaccines Product Portfolio
- 6.9.5 MEVAC Recent Developments
- 6.10 Nisseiken
- 6.10.1 Nisseiken Company Information
- 6.10.2 Nisseiken Business Overview
- 6.10.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Nisseiken Livestock Vaccines Product Portfolio
- 6.10.5 Nisseiken Recent Developments
- 6.11 Phibro Animal Health Corporation
- 6.11.1 Phibro Animal Health Corporation Company Information
- 6.11.2 Phibro Animal Health Corporation Business Overview
- 6.11.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
- 6.11.5 Phibro Animal Health Corporation Recent Developments
- 6.12 Pulike
- 6.12.1 Pulike Company Information
- 6.12.2 Pulike Business Overview
- 6.12.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Pulike Livestock Vaccines Product Portfolio
- 6.12.5 Pulike Recent Developments
- 6.13 QYH Biotech Co., Ltd
- 6.13.1 QYH Biotech Co., Ltd Company Information
- 6.13.2 QYH Biotech Co., Ltd Business Overview
- 6.13.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
- 6.13.5 QYH Biotech Co., Ltd Recent Developments
- 6.14 Vaxxinova®
- 6.14.1 Vaxxinova® Company Information
- 6.14.2 Vaxxinova® Business Overview
- 6.14.3 Vaxxinova® Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Vaxxinova® Livestock Vaccines Product Portfolio
- 6.14.5 Vaxxinova® Recent Developments
- 6.15 Venky's
- 6.15.1 Venky's Company Information
- 6.15.2 Venky's Business Overview
- 6.15.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Venky's Livestock Vaccines Product Portfolio
- 6.15.5 Venky's Recent Developments
- 6.16 Zoetis
- 6.16.1 Zoetis Company Information
- 6.16.2 Zoetis Business Overview
- 6.16.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Zoetis Livestock Vaccines Product Portfolio
- 6.16.5 Zoetis Recent Developments
- 6.17 Merck
- 6.17.1 Merck Company Information
- 6.17.2 Merck Business Overview
- 6.17.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Merck Livestock Vaccines Product Portfolio
- 6.17.5 Merck Recent Developments
7 North America by Country
- 7.1 North America Livestock Vaccines Sales by Country
- 7.1.1 North America Livestock Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Livestock Vaccines Sales by Country (2021-2026)
- 7.1.3 North America Livestock Vaccines Sales Forecast by Country (2027-2032)
- 7.2 North America Livestock Vaccines Market Size by Country
- 7.2.1 North America Livestock Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Livestock Vaccines Market Size by Country (2021-2026)
- 7.2.3 North America Livestock Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Livestock Vaccines Sales by Country
- 8.1.1 Europe Livestock Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Livestock Vaccines Sales by Country (2021-2026)
- 8.1.3 Europe Livestock Vaccines Sales Forecast by Country (2027-2032)
- 8.2 Europe Livestock Vaccines Market Size by Country
- 8.2.1 Europe Livestock Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Livestock Vaccines Market Size by Country (2021-2026)
- 8.2.3 Europe Livestock Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Livestock Vaccines Sales by Country
- 9.1.1 Asia-Pacific Livestock Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Livestock Vaccines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Livestock Vaccines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Livestock Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Livestock Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Livestock Vaccines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Livestock Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Livestock Vaccines Sales by Country
- 10.1.1 South America Livestock Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Livestock Vaccines Sales by Country (2021-2026)
- 10.1.3 South America Livestock Vaccines Sales Forecast by Country (2027-2032)
- 10.2 South America Livestock Vaccines Market Size by Country
- 10.2.1 South America Livestock Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Livestock Vaccines Market Size by Country (2021-2026)
- 10.2.3 South America Livestock Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Livestock Vaccines Sales by Country
- 11.1.1 Middle East and Africa Livestock Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Livestock Vaccines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Livestock Vaccines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Livestock Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Livestock Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Livestock Vaccines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Livestock Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Livestock Vaccines Value Chain Analysis
- 12.1.1 Livestock Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Livestock Vaccines Production Mode & Process
- 12.2 Livestock Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Livestock Vaccines Distributors
- 12.2.3 Livestock Vaccines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst